Beaton Management Co. Inc. Purchases Shares of 2,150 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Beaton Management Co. Inc. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,150 shares of the exchange traded fund’s stock, valued at approximately $212,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund increased its position in SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock valued at $297,575,000 after purchasing an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in shares of SPDR S&P Biotech ETF by 1.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after buying an additional 18,202 shares during the period. Jane Street Group LLC raised its stake in SPDR S&P Biotech ETF by 68.7% during the first quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares during the last quarter. Bessemer Group Inc. raised its stake in SPDR S&P Biotech ETF by 1.7% during the first quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after buying an additional 15,794 shares during the last quarter. Finally, Mirae Asset Securities USA Inc. lifted its holdings in SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Trading Down 5.3 %

Shares of SPDR S&P Biotech ETF stock opened at $91.83 on Friday. The business has a 50-day moving average price of $98.95 and a two-hundred day moving average price of $96.11. SPDR S&P Biotech ETF has a 1-year low of $69.32 and a 1-year high of $105.47. The company has a market cap of $7.00 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.